These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1657090)

  • 21. Gastrointestinal cancer in the elderly.
    Wallach CB; Kurtz RC
    Gastroenterol Clin North Am; 1990 Jun; 19(2):419-32. PubMed ID: 2163983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arterial infusion of antineoplastic agents in neoplasms of liver, biliary tract and pancreas--one shot method and continuous infusion].
    Akiba M; Aizawa Y; Shimizu Y; Kameda H
    Nihon Rinsho; 1982; 40(1):175-82. PubMed ID: 7087201
    [No Abstract]   [Full Text] [Related]  

  • 23. [Liver, pancreas, biliary tract cancer].
    Miyazaki M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1477. PubMed ID: 23130370
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral methotrexate therapy of gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG
    Surg Gynecol Obstet; 1970 Feb; 130(2):292-4. PubMed ID: 4189074
    [No Abstract]   [Full Text] [Related]  

  • 25. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
    Ramanathan RK; Belani CP; Singh DA; Tanaka M; Lenz HJ; Yen Y; Kindler HL; Iqbal S; Longmate J; Mack PC; Lurje G; Gandour-Edwards R; Dancey J; Gandara DR
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):777-83. PubMed ID: 19169683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
    Lang A; Graeven U
    Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
    [No Abstract]   [Full Text] [Related]  

  • 27. Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
    Heise C; Nieto AE; Scheck MK; Ekmekciu I; Sommerhäuser G; Reinacher-Schick A; Hofheinz RD; Lorenzen S; Wege H; Kunzmann V; Götze TO; Mavroeidi IA
    Oncol Res Treat; 2024; 47(5):233-237. PubMed ID: 38387453
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial.
    Ravry MJ; Omura GA; Bartolucci AA; Einhorn L; Kramer B; Davila E
    Cancer Treat Rep; 1986 Feb; 70(2):311-2. PubMed ID: 3004729
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy and medical treatment of hepatocellular carcinoma (HCC).
    Rougier P; Mitry E; Clavero-Fabri MC
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1264-6. PubMed ID: 9730386
    [No Abstract]   [Full Text] [Related]  

  • 30. [Liver, pancreas, biliary tract cancer].
    Miyazaki M
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1295-6. PubMed ID: 24312978
    [No Abstract]   [Full Text] [Related]  

  • 31. Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators.
    Cho C; Wust P; Hildebrandt B; Issels RD; Sehouli J; Kerner T; Deja M; Budach V; Gellermann J
    Int J Hyperthermia; 2008 Aug; 24(5):399-408. PubMed ID: 18608591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
    DeLeon TT; Ahn DH; Bogenberger JM; Anastasiadis PZ; Arora M; Ramanathan RK; Aqel BA; Vasmatzis G; Truty MJ; Oklu R; Bekaii-Saab TS; Borad MJ
    Future Oncol; 2018 Mar; 14(6):553-566. PubMed ID: 29460642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies.
    McNamara MG
    Curr Probl Cancer; 2018; 42(1):8-11. PubMed ID: 29397186
    [No Abstract]   [Full Text] [Related]  

  • 34. Continuous hepatic arterial infusion chemotherapy for liver metastasis from biliary tract and pancreatic cancers.
    Kato Y; Tsuyuki A; Kikuchi K; Tokuyama J; Kurihara N; Kumamoto Y; Fujishiro Y; Ebinuma H
    Anticancer Res; 2005; 25(1B):477-82. PubMed ID: 15816615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and targeted therapy for biliary tract tumors and primary liver tumors.
    Thomas MB
    Surg Oncol Clin N Am; 2014 Apr; 23(2):369-81. PubMed ID: 24560115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress in the treatment of hepatocellular carcinoma.
    Roh MS
    Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
    [No Abstract]   [Full Text] [Related]  

  • 37. The microbiome and hepatobiliary-pancreatic cancers.
    Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
    Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adjuvant chemotherapy in cancers of the stomach, pancreas and intestine].
    Martin F
    Bull Cancer; 1984; 71(4):374-6. PubMed ID: 6498350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic and hepatobiliary cancers: adjuvant therapy and management of inoperable disease.
    Glimelius B
    Ann Oncol; 2000; 11 Suppl 3():153-9. PubMed ID: 11079133
    [No Abstract]   [Full Text] [Related]  

  • 40. [The current status of chemo- or immunotherapy of gastrointestinal tumors].
    Schmidt M; Gropp C; Martini GA
    Internist (Berl); 1978 Dec; 19(12):692-9. PubMed ID: 217849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.